Key result
Incomplete surgical resection is linked to a ~10-fold higher risk of postoperative VTE.
Why the study?
Clinical risk factors for venous thromboembolism in postoperative lung cancer patients were not well defined to guide prevention and treatment.
What are the clinical risk factors for venous thromboembolism in postoperative lung cancer patients?
Cohort (n=1,001)
What are the clinical risk factors for venous thromboembolism in postoperative lung cancer patients?
Incomplete surgical resection, anti-angiogenesis drugs, EGFR-TKI use, and elevated preoperative D-dimer are significant risk factors for VTE in postoperative lung cancer patients.
Answers are grounded in this paper and cite their sources.
Warrants caution in high-risk patients after cancer surgery; leaves open whether targeted prophylaxis reduces VTE.
BACKGROUND AND OBJECTIVES: The objective of this study is to explore clinical risk factors for venous thromboembolism (VTE) in postoperative lung cancer patients in order to provide a basis for the prevention and treatment of postoperative VTE. METHODS: A total of 1,001 lung cancer patients were retrospectively analyzed. Each patient was confirmed with surgical pathology diagnosis and had a complete clinical and follow-up record. VTE was identified in a combination of spiral computed tomography (CT), pulmonary angiography, and color Doppler ultrasound. We used life table method to create an occurrence frequency curve of thrombosis. We also searched for high risk factors for postoperative VTE with Cox multivariate regression model and created frequency curves of thrombosis against different risk factors using Kaplan-Meier method. RESULTS: As of July 31, 2011, the median follow-up time is 25.73 ± 0.11 months (19.23-31.37). The cumulative frequency of VTE among 1,001 lung cancer patients is 2%, 3%, 4%, 5%, and 5.3% over 1, 3, 6, 12, and 30 months after the surgery. COX regression analysis showed that the hazard ratio of VTE occurrence in patients with incomplete resection relative to ones with complete resection is 9.867 (95% CI: 5.275-18.459, P = 0.000). And the hazard ratio of VTE occurrence is 3.472 (95% CI: 1.761-6.845, P = 0.000) in patients with anti-angiogenesis treatment compared to patients without such treatment. The hazard ratio of VTE occurrence is 2.808 (95% CI: 1.439-5.479, P = 0.002) in patients with EGFR-TKI treatment relative to patients without the treatment, and 7.520 (95% CI: 3.968-14.250, P = 0.000) in patients with an increase in D-dimer level relative to normal ones CONCLUSIONS: The highest incidence of VTE is within 1 month after lung cancer surgery. High risk factors for VTE include incomplete surgical resection, postoperative use of anti-angiogenesis drugs, EGFR-TKI application and an increase in preoperative D-dimer level.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2012) conducted a cohort in Lung cancer (n=1,001). Incomplete surgical resection vs. Complete surgical resection was evaluated on Venous thromboembolism (VTE) (HR 9.867, 95% CI 5.275-18.459, p=0.000). Incomplete surgical resection, anti-angiogenesis treatment, EGFR-TKI treatment, and increased D-dimer were significant risk factors for postoperative VTE.
Synapse has enriched 10 related papers. Consider them for comparative context: